ForViva’s (FVA) “Buy” Rating Reaffirmed at Canaccord Genuity Group

Canaccord Genuity Group reissued their buy rating on shares of ForViva (LON:FVAFree Report) in a research report report published on Wednesday morning,Digital Look reports. Canaccord Genuity Group currently has a GBX 190 target price on the stock.

Separately, Shore Capital Group reissued a “hold” rating on shares of ForViva in a report on Friday, April 17th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, ForViva has an average rating of “Moderate Buy” and a consensus target price of GBX 190.

Read Our Latest Research Report on FVA

ForViva Stock Performance

Shares of FVA opened at GBX 129.50 on Wednesday. ForViva has a 52-week low of GBX 114.50 and a 52-week high of GBX 140. The company has a market cap of £67.07 million and a price-to-earnings ratio of 5.66. The firm has a fifty day simple moving average of GBX 129.24.

ForViva (LON:FVAGet Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported GBX 11 earnings per share for the quarter. The business had revenue of GBX 5,057 million for the quarter.

ForViva Company Profile

(Get Free Report)

ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.

Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.

See Also

Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.